Overview

ExploRNA Therapeutics develops groundbreaking innovations of mRNA as a therapeutic platforms paving the way for new therapeutic applications. Recent year has shown that companies using mRNA technologies are in the forefront of fighting the coronavirus pandemic and the technology has the potential to revolutionise the pharmaceutical industry. The first mRNA modification invention of ExploRNA team was licensed a decade ago by BioNTech and since then has been used in cancer vaccine clinical trials.